<ns0:re3data xmlns:ns0="http://www.re3data.org/schema/2-2" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.re3data.org/schema/2-2 http://schema.re3data.org/2-2/re3dataV2-2.xsd">
    <ns0:repository>
        <ns0:re3data.orgIdentifier>r3d100010614</ns0:re3data.orgIdentifier>
        <ns0:repositoryName language="eng">Follicular Lymphoma Genome Data at Canada's Michael Smith Genome Sciences Centre (BCGSC)</ns0:repositoryName>
                <ns0:repositoryURL>http://www.bcgsc.ca/data/hra-follicular-lymphoma</ns0:repositoryURL>
                <ns0:description language="eng">Mapping, copy number analysis, sequence and gene expression data generated by the High Resolution Analysis of Follicular Lymphoma Genomes project. The data will be available for 24 patients with follicular lymphoma. All data will be made as widely and freely available as possible while safeguarding the privacy of participants, and protecting confidential and proprietary data.The data from this project will be submitted to public genomic data sources. These sources will be listed on this web site as the data becomes available in these external data sources.</ns0:description>
                    <ns0:repositoryContact>info@bcgsc.ca</ns0:repositoryContact>
                            <ns0:type>disciplinary</ns0:type>
                    <ns0:type>institutional</ns0:type>
                <ns0:size updated="" />
        <ns0:startDate>2004</ns0:startDate>
        <ns0:endDate />
                    <ns0:repositoryLanguage>eng</ns0:repositoryLanguage>
                            <ns0:subject subjectScheme="DFG">2 Life Sciences</ns0:subject>
                    <ns0:subject subjectScheme="DFG">201 Basic Biological and Medical Research</ns0:subject>
                    <ns0:subject subjectScheme="DFG">20105 General Genetics</ns0:subject>
                    <ns0:subject subjectScheme="DFG">204 Microbiology, Virology and Immunology</ns0:subject>
                    <ns0:subject subjectScheme="DFG">205 Medicine</ns0:subject>
                    <ns0:subject subjectScheme="DFG">20503 Human Genetics</ns0:subject>
                    <ns0:subject subjectScheme="DFG">20532 Biomedical Technology and Medical Physics</ns0:subject>
                    <ns0:subject subjectScheme="DFG">21 Biology</ns0:subject>
                    <ns0:subject subjectScheme="DFG">22 Medicine</ns0:subject>
                <ns0:missionStatementURL />
                    <ns0:contentType contentTypeScheme="parse">Databases</ns0:contentType>
                    <ns0:contentType contentTypeScheme="parse">Raw data</ns0:contentType>
                    <ns0:contentType contentTypeScheme="parse">Scientific and statistical data formats</ns0:contentType>
                    <ns0:contentType contentTypeScheme="parse">Software applications</ns0:contentType>
                    <ns0:contentType contentTypeScheme="parse">Structured graphics</ns0:contentType>
                    <ns0:contentType contentTypeScheme="parse">other</ns0:contentType>
                            <ns0:providerType>dataProvider</ns0:providerType>
                            <ns0:keyword>Fingerprinted Contigs(FPC)</ns0:keyword>
                    <ns0:keyword>genome</ns0:keyword>
                    <ns0:keyword>human</ns0:keyword>
                    <ns0:keyword>medical study data</ns0:keyword>
                            <ns0:institution>
                <ns0:institutionName language="eng">BC Cancer Foundation</ns0:institutionName>
                                <ns0:institutionCountry>CAN</ns0:institutionCountry>
                                    <ns0:responsibilityType>funding</ns0:responsibilityType>
                                <ns0:institutionType>non-profit</ns0:institutionType>
                <ns0:institutionURL>http://bccancerfoundation.com/</ns0:institutionURL>
                                <ns0:responsibilityStartDate />
                <ns0:responsibilityEndDate />
                            </ns0:institution>
                    <ns0:institution>
                <ns0:institutionName language="eng">Canada's Michael Smith Genome Sciences Centre</ns0:institutionName>
                                    <ns0:institutionAdditionalName language="eng">BC Cancer Agency, Research Centre</ns0:institutionAdditionalName>
                                    <ns0:institutionAdditionalName language="eng">BCGSC</ns0:institutionAdditionalName>
                                <ns0:institutionCountry>CAN</ns0:institutionCountry>
                                    <ns0:responsibilityType>general</ns0:responsibilityType>
                                    <ns0:responsibilityType>technical</ns0:responsibilityType>
                                <ns0:institutionType>non-profit</ns0:institutionType>
                <ns0:institutionURL>http://www.bcgsc.ca/data</ns0:institutionURL>
                                <ns0:responsibilityStartDate />
                <ns0:responsibilityEndDate />
                                    <ns0:institutionContact>http://www.bcgsc.ca/about/contacts</ns0:institutionContact>
                                    <ns0:institutionContact>http://www.bcgsc.ca/author/adrobnies</ns0:institutionContact>
                            </ns0:institution>
                    <ns0:institution>
                <ns0:institutionName language="eng">High Resolution Analysis of Follicular Lymphoma Genomes Project</ns0:institutionName>
                                    <ns0:institutionAdditionalName language="eng">BCGSC</ns0:institutionAdditionalName>
                                <ns0:institutionCountry>CAN</ns0:institutionCountry>
                                    <ns0:responsibilityType>general</ns0:responsibilityType>
                                <ns0:institutionType>non-profit</ns0:institutionType>
                <ns0:institutionURL>http://www.bcgsc.ca/project/high-resolution-analysis-of-follicular-lymphoma-genomes</ns0:institutionURL>
                                <ns0:responsibilityStartDate />
                <ns0:responsibilityEndDate />
                                    <ns0:institutionContact>jschein@bcgsc.ca</ns0:institutionContact>
                            </ns0:institution>
                            <ns0:policy>
                <ns0:policyName>Data Release Policy</ns0:policyName>
                <ns0:policyURL>http://www.bcgsc.ca/data/data-release-open-access</ns0:policyURL>
            </ns0:policy>
                <ns0:databaseAccess>
            <ns0:databaseAccessType>open</ns0:databaseAccessType>
                    </ns0:databaseAccess>
                            <ns0:dataAccess>
                <ns0:dataAccessType>open</ns0:dataAccessType>
                            </ns0:dataAccess>
                            <ns0:dataLicense>
                <ns0:dataLicenseName>CC</ns0:dataLicenseName>
                <ns0:dataLicenseURL>http://creativecommons.org/licenses/by/2.5/</ns0:dataLicenseURL>
            </ns0:dataLicense>
                    <ns0:dataLicense>
                <ns0:dataLicenseName>other</ns0:dataLicenseName>
                <ns0:dataLicenseURL>http://www.bcgsc.ca/data/data-release-open-access</ns0:dataLicenseURL>
            </ns0:dataLicense>
                            <ns0:dataUpload>
                <ns0:dataUploadType>restricted</ns0:dataUploadType>
                                    <ns0:dataUploadRestriction>registration</ns0:dataUploadRestriction>
                            </ns0:dataUpload>
                                    <ns0:software>
                <ns0:softwareName>unknown</ns0:softwareName>
            </ns0:software>
                <ns0:versioning />
                            <ns0:pidSystem>none</ns0:pidSystem>
                <ns0:citationGuidelineURL>http://www.bcgsc.ca/data/data-release-open-access</ns0:citationGuidelineURL>
                <ns0:enhancedPublication>unknown</ns0:enhancedPublication>
        <ns0:qualityManagement>unknown</ns0:qualityManagement>
                                <ns0:remarks>Follicular lymphoma (FL), the most common type of lymphoma, is a cancer of the cells of the immune system. Follicular lymphoma is associated with a specific genome rearrangement where parts of chromosomes 14 and 18 have exchanged. This rearrangement is an initiating event for FL but insufficient without additional mutation events for cancer development. Furthermore, there may be more genome rearrangements to progress from FL to a more aggressive form of the disease, diffuse large B-cell lymphoma. To understand the relationship between rearrangements and disease, this project will identify rearrangements in the FL genome and then analyze the rearrangements to determine their effect on gene structure. Because this is one of the first in depth genome profiling of human cancers, recurrent genomic rearrangements will advance knowledge not only about lymphoma but about cancer in general. Understanding the dysfunctions in lymphoma will permit researchers to develop new diagnostic and prognostic markers and possibly new therapies.</ns0:remarks>
        <ns0:entryDate>2014-02-20</ns0:entryDate>
        <ns0:lastUpdate>2021-08-25</ns0:lastUpdate>
    </ns0:repository>
</ns0:re3data>